Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Marksans Pharma Ltd. Capital/Financing Update 2023

Feb 7, 2023

62142_rns_2023-02-07_87bc8f02-dd72-4ca3-b307-fb427f68dc73.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [226 x 74] intentionally omitted <==

----- Start of picture text ----- ·4·Marksans Pharma Ltd.----- End of picture text -----

To,

National Stock Exchange of India Limited Exchange Plaza Bandra Kurla Complex Bandra (E), Mumbai - 400051

To, BSE Limited P. J. Towers Dalal Street Mumbai - 400 001

Sub: Intimation of Credit Ratings of Marksans Pharma Limited by CARE Ratings Ltd

We wish to inform that CARE Ratings Ltd. has assigned following credit ratings to the Bank facilities of Marksans Pharma Limited:-

==> picture [477 x 102] intentionally omitted <==

----- Start of picture text ----- Instrument Type Amount Rating / Outlook Rating Action(Rs. in Crore)Fund-based Bank 160.00 CARE A+; Stable Rating Reaffirmed;Facilities Outlook revised toCAREAl+Non-fund-based Bank 95.75 CAREAl+ Rating ReaffirmedFacilities----- End of picture text -----

Yours faithfully, For Marksans Pharma Limited

HARSHAVA Digitally signed by HARSHAVARDHAN RDHAN PANIGRAHI Date: 2023.02.07 PANIGRAHI 11:33:03 +05'30' Harshavardhan Panigrahi

Company Secretary & Compliance Officer

www.marksanspharma.com